| Hodgkin Lymphoma | HL | Brentuximab vedotin | cytochrome c | CYCS | cell lines | 26811457 | Details |  |  |  |  |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-9 | CASP9 | cell lines | 26811457 | Details |  |  |  |  |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details |  |  |  |  |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details |  |  |  |  |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details |  |  |  |  |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details |  |  |  |  |
| Lymphoma | DLBC | SR0987 | IL-17 | IL17A | cell lines | 26785144 | Details |  |  |  |  |
| Lymphoma | DLBC | SR0987 | PD-1 | PDCD1 | cell lines | 26785144 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | caspase-3 | CASP3 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IDO | IDO1 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD8+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Cytotoxic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper1 (Th1) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper2 (Th2) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper17 (Th17) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Transitional B cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Follicular helper (Tfh) T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4-CD28+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4-CD28- T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Activated CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Naive T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Central memory T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Effector memory T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Effector T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Angiogenic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Naive CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Activated T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4+CD25+ regulatory T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD8+ cytotoxic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Exhausted T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper9 (Th9) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Naive CD8+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Mucosal-associated invariant T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Exhausted CD8+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Exhausted CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4+ cytotoxic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IL-12 | IL12B | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IL-12 | IL12A | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | TGF-β | TGFB1 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | CCL2 | CCL2 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | VEGF | VEGFA | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | CCL22 | CCL22 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | COX-2 | PTGS2 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IL-10 | IL10 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | cleaved caspase-3 | CASP3 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IDO | IDO1 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD8+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Cytotoxic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper1 (Th1) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper2 (Th2) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper17 (Th17) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Transitional B cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Follicular helper (Tfh) T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4-CD28+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4-CD28- T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Activated CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Naive T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Central memory T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Effector memory T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Effector T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Angiogenic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Naive CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Activated T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4+CD25+ regulatory T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD8+ cytotoxic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Exhausted T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | T helper9 (Th9) cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Naive CD8+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Mucosal-associated invariant T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Exhausted CD8+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | Exhausted CD4+ T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | T lymphocytes | CD4+ cytotoxic T cell | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IL-12 | IL12B | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IL-12 | IL12A | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | TGF-β | TGFB1 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | CCL2 | CCL2 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | VEGF | VEGFA | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | CCL22 | CCL22 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | COX-2 | PTGS2 | mouse model | 26683520 | Details |  |  |  |  |
| T Lymphoma | TL | ACT CD8+ T-cells | IL-10 | IL10 | mouse model | 26683520 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | A20 | TNFAIP3 | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | MDSCs | Myeloid-derived suppressor cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD8+ T cells | Naive CD8+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD8+ T cells | Effector CD8+ memory T (Tem) cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD8+ T cells | Exhausted CD8+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD8+ T cells | CD8+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD8+ T cells | CD8+ cytotoxic T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD69+ CD8+ T cells | Exhausted CD8+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD69+ CD8+ T cells | Exhausted CD8+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD69+ CD8+ T cells | Exhausted CD8+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD4+ IFN-γ+ T cells | Exhausted CD4+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD8+ IFN-γ+ T cells | CD8+ cytotoxic T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD8+ IFN-γ+ T cells | Exhausted CD8+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | CD4+ FoxP3+ Tregs | CD4+ T cell | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | p-JNK | MAPK9 | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | cleaved caspase-3 | CASP3 | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoma | DLBC | si-A20 | cleaved caspase-3 | CASP3 | mouse model | 26561336 | Details |  |  |  |  |
| Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | DLBC | Chimeric antigen receptor T-cell (CART) | CD19 | CD19 | clinical trial phase 1 | 29126866 | Details |  |  |  |  |
| Follicular Lymphoma | DLBC | Rituximab | PD-1 | PDCD1 | clinical trail | 21237493 | Details |  |  |  |  |
| Lymphoma | DLBC | SB415286 | PD-1 | PDCD1 | mouse model | 29055015 | Details |  |  |  |  |
| Lymphoma | DLBC | SB415286 | granzyme B | GZMB | mouse model | 29055015 | Details |  |  |  |  |
| Lymphoma | DLBC | SB415286 | LAMP1 | LAMP1 | mouse model | 29055015 | Details |  |  |  |  |
| Lymphoma | DLBC | SB415286 | Tbx21 | TBX21 | mouse model | 29055015 | Details |  |  |  |  |
| Non Hodgkin Lymphoma | NHL | rituximab | CD20 | MS4A1 | clinical trail | 28097046 | Details |  |  |  |  |
| Lymphoma | DLBC | polyfunctional CD4+ T cells | IFN-γ | IFNG | mouse model | 27471650 | Details |  |  |  |  |
| Lymphoma | DLBC | polyfunctional CD4+ T cells | IL-2 | IL2 | mouse model | 27471650 | Details |  |  |  |  |
| Lymphoma | DLBC | polyfunctional CD4+ T cells | TNF-α | TNF | mouse model | 27471650 | Details |  |  |  |  |
| Lymphoma | DLBC | polyfunctional CD4+ T cells | PD-1 | PDCD1 | mouse model | 27471650 | Details |  |  |  |  |
| Lymphoma | DLBC | polyfunctional CD4+ T cells | FoxP3 | FOXP3 | mouse model | 27471650 | Details |  |  |  |  |